KAYLEY EPTING: Open Payments
NPI 1407591209 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 35 payments from 20 companies in 2025. Trend: 2023 $1,215 · 2024 $1,301 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Novo Nordisk Inc | 3 | $62 |
| Amgen Inc. | 3 | $52 |
| Stryker Corporation | 1 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
Products named: VRAYLAR, Wegovy, CLOTTRIEVER BOLD CATHETER, TRELEGY ELLIPTA, AIRSUPRA, OTEZLA, XIFAXAN, FARXIGA.
Industry payments across SC — which companies pay providers there.
